KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,964,000 | -16.3% | 909,083 | -30.9% | 0.29% | +0.3% |
| Q2 2022 | $5,934,000 | -40.1% | 1,315,834 | -2.2% | 0.29% | -27.3% |
| Q1 2022 | $9,912,000 | +20.7% | 1,344,929 | +5.3% | 0.40% | +35.7% |
| Q4 2021 | $8,209,000 | +0.6% | 1,276,634 | -8.9% | 0.29% | -3.3% |
| Q3 2021 | $8,159,000 | -43.9% | 1,401,861 | -0.5% | 0.30% | -41.8% |
| Q2 2021 | $14,545,000 | -11.5% | 1,409,397 | -9.8% | 0.52% | -3.5% |
| Q1 2021 | $16,443,000 | -31.6% | 1,563,044 | +0.7% | 0.54% | -36.6% |
| Q4 2020 | $24,033,000 | +13.1% | 1,552,504 | +6.7% | 0.85% | -1.2% |
| Q3 2020 | $21,246,000 | +47.2% | 1,455,222 | +91.0% | 0.86% | +38.3% |
| Q2 2020 | $14,429,000 | +25.9% | 761,819 | +27.7% | 0.62% | -3.4% |
| Q1 2020 | $11,463,000 | – | 596,745 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |